Dipharma Granted CADIFA By ANVISA For Ursodeoxycholic Acid
15 Oct 2024 //
PRESS RELEASE
Dipharma Attends XXVIII Italian Chemical Society Congress
27 Aug 2024 //
PRESS RELEASE
Dipharma & Flow Chemistry: Lesson at University, CNR, and Industry Meeting
18 Jun 2024 //
PRESS RELEASE
API Production: Technology Transfer and Troubleshooting Management
17 Jun 2024 //
PRESS RELEASE
ISOS 2024: Dipharma Sponsors with Key Poster Presentation
07 Jun 2024 //
PRESS RELEASE
Dipharma Francis Appoints New Board Of Directors
22 May 2024 //
PRESS RELEASE
Dipharma contributes to the U.S. Life Sciences 2024 publication
07 May 2024 //
PRESS RELEASE
Pharma Tech Outlook awards Dipharma as one of the Top CMOs in 2024
06 May 2024 //
PRESS RELEASE
Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA
06 May 2024 //
GLOBENEWSWIRE
Dipharma Receives the 2nd GMP Certification from Brazilian ANVISA
26 Oct 2023 //
GLOBENEWSWIRE
Dipharma expands its Italian R&D Center to increase its analytical services
04 Apr 2023 //
GLOBENEWSWIRE
Dipharma Expands Italian R&D Center to Increase Analytical Services
04 Apr 2023 //
CONTRACT PHARMA
Dipharma Completes Second Phase of CGMP Expansion at Kalamazoo Site
10 Feb 2023 //
CONTRACT PHARMA
Dipharma completes second phase of CGMP expansion at its Kalamazoo site
10 Feb 2023 //
GLOBENEWSWIRE
Dipharma`s Sapropterin Receives Approval in the Europe
17 Nov 2022 //
EMA
Dipharma’s New Production Line Approved by the Italian Medicines Agency
11 Oct 2022 //
CONTRACTPHARMA
Dipharma Receives Regulatory Authorization for New Line at Its cGMP Pilot Plant
06 Oct 2022 //
BUSINESSWIRE
EffRx Pharma introduces Miglustat Dipharma 100 mg capsules in Switzerland
16 Feb 2021 //
PHARMABIZ
Dipharma Francis S.r.l. Announces Changes in the Leadership Positions
03 Sep 2019 //
BUSINESSWIRE
Dipharma Francis S.r.l. Enters into Agreement to Acquire Kalexsyn Inc.
23 Apr 2018 //
BUSINESSWIRE
Dipharma Francis divests Malta-based subsidiary, Amino Chemicals ABA Chemicals
05 Jul 2017 //
PHARMABIZ
Dipharma Announces Successful development of a stable, fast dissolving tablet Formulation of carglumic acid
05 Apr 2017 //
PRESS RELEASE
Dipharma announces the validation of disanit® (nitisinone) marketing authorization application in Europe
23 Feb 2017 //
PRESS RELEASE
Dipharma & Alvogen announce launch of Diterin® 100mg tablets in South Korea
03 Feb 2017 //
PRESS RELEASE
AMERIGEN and DIPHARMA announce first regulatory submission for Miglustat 100mg Capsules
21 Mar 2016 //
PR NEWSWIRE
AMERIGEN and DIPHARMA announce first regulatory submission for Miglustat
11 Jan 2016 //
PR NEWS WIRE